Clinical Trial Update: HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HR-positive, HER2-negative advanced breast cancer after progression on endocrine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Taizhou EOC Pharma Co., Ltd. | Conditions: Solid Tumor, Adult | Phase 2 | Status: UNKNOWN